<DOC>
	<DOCNO>NCT00716391</DOCNO>
	<brief_summary>An Open Label Randomized , Multi-Centre Phase III Trial TPF Chemotherapy Plus Concomitant Treatment With Cisplatin Conventional Radiotherapy Versus TPF Chemotherapy Plus Concomitant Cetuximab Conventional Radiotherapy Locally Advanced , Unresectable Head Neck Cancer .</brief_summary>
	<brief_title>TPF Plus Cisplatin Radiotherapy v TPF Plus Cetuximab Radiotherapy Treat Head Neck Cancer .</brief_title>
	<detailed_description>This study sponsor cooperative medical group .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>1 . Before begin protocol 's specific procedure , inform consent obtain . 2 . Locally advanced cancer head neck ( oral cavity , oropharynx , larynx hypopharynx ) stage IIIIV , without evidence metastasis . 3 . The tumor must consider nonoperable accord criterion Northern California Oncology Group . The reason nonsurgical resection annotate CRF . Criteria nonsurgical resection accord NCOG : 3.1.Technically resectable ( include : evidence mediastinal dissemination ; fix tumor clavicle , base cranium cervical vertebra ; affectation nasopharynx ) . 3.2.Medical criterion base low surgical curability . 3.3.Medical contraindication surgery . 4 . Epidermoid carcinoma histologically demonstrate 5 . Measurable disease accord RECIST criterion . 6 . Men woman age 18 70 year , inclusive . 7 . Functional condition index accord ECOG scale:01 8 . Patients medical condition able receive treatment TPF induction follow normofractionated radiotherapy cetuximab cisplatin . 9 . Patients adequate hematologic function : neutrophils superior equal 2 x 109 , platelet superior equal 100 x 109 , hemoglobin superior equal 10 g/dl . 10 . Adequate hepatic function : bilirubin lower equal 1 x top normal Limit , GOT GPT low equal 2,5 Top Normal Limit , alkaline phosphatase &lt; 5 Top Normal Limit . 11 . Adequate renal function : creatinin &lt; 1,4 mg/dl ( 120 Âµmol/l ) ; value &gt; 1,4 mg/dl , clearance creatinin &gt; 60 ml/min ( real calculate CockcroftGault 's method ) . 12 . Calcium low equal 1,25 x top normal limit . 13 . Adequate nutritional condition : loss weight &lt; 20 % relation theoretical weight albumin superior equal 35 g/L . 14 . Patients must accessible treatment followup . 1 . Metastatic disease 2 . Surgical treatment , previous radiotherapy and/or chemiotherapy study disease . 3 . Other tumour location head neck oral cavity , oropharynx , larynx , hypopharynx . 4 . Other stage III IVM0 . 5 . Other previous / synchronic squamous carcinoma . 6 . Diagnosis another neoplasia last 5 year , except carcinoma situ uterine neck and/or cutaneous carcinoma basocellular properly treat . 7 . Active infection ( need endovenous antibiotic ) , include active tuberculosis diagnose HIV . 8 . Not control hypertension define arterial systolic tension superior equal 180 mm Hg / diastolic arterial tension superior equal 130 mm Hg baseline . 9 . Pregnancy ( absence must confirm test betaHCG ) period lactation . 10 . Immunity systemic treatment , chronic concomitant , hormonal treatment cancer . 11 . Other antineoplastic concomitant treatment . 12 . Coronary clinically significant arteriopathy precedent myocardial infarction last 12 month high risk control arrhythmia cardiac control insufficiency . 13 . Pulmonary obstructive chronic disease need 3 hospitalization last 12 month . 14 . Active non control peptic ulcer . 15 . Presence psychological medical disease could prevent accomplish study patient grant his/her signature inform consent form . 16 . Known drug abuse ( exception excessive consumption alcohol ) 17 . Known allergic reaction component treatment study . 18 . Previous treatment monoclonal antibody transduction sign inhibitor treatment direct EGFR . 19 . Any experimental treatment 30 day entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Head Neck Cancer</keyword>
</DOC>